π£ Hot off the press (June 22)! π
π€²π½ Honored to share the publication of findings from the β
#LivingDonorExtended Time Outcomesβ (
#LETO) Study, an ancillary study of the β
#APOL1 Long-term Kidney Transplantation Outcomesβ (
#APOLLO) Network Study:
β
#Apolipoprotein L1 Gene Genotype and Kidney Outcomes After
#LivingKidneyDonationβ
𧬠Key finding: APOL1 genotype is a significant risk factor for reduced kidney function following living kidney donation. These results support
#APOL1Genotyping for Black living kidney donor candidates in the U.S. to improve risk stratification and informed decision-making.
π Read the
@JAMAInternalMed article:
jamanetwork.com/journals/jamβ¦
π€ If youβre attending the
@ATCMeeting (
#ATC) 2026, please join us for presentations on LETO:
β’ June 23, 9:00 AM β Abstract 921, Plenary Session | Ballroom
β’ June 23, 10:09 AM β Abstract 938 | Room 253A
ππ½We are grateful to the @NIDDKgov for funding this work and to our outstanding collaborators: Chi-yuan Hsu, Ying Gao, Barry I. Freedman,
@MitchellLunn , Anthony Muiru, Mark Schnitzler, Jasmin Divers,
@mannonmom, Nicholette Palmer, Amy Karger,
@KristaLentine *, and
@emp802* |
@UCSFTransplant |
@slunephrons |
@SSMHealthSTL |
@slusom |
@wakeforestmed |
@NebraskaMed |
@nyuniversity π«ΆπΌ
π€π½ We look forward to the discussion and to advancing our understanding of
#genetic tools that can help improve the safety and long-term outcomes of living kidney donation.π§¬
ππ
#KidneyDonation #Transplantation #LivingDonation #PrecisionMedicine #Genetics #APOL1 #APOLLOStudy #LETO #ClinicalResearch #ATC2026 π¦